Marcadores tumorales: CA 72-4 y CYFRA 21-1 - Cibic Laboratorios
What is Cyfra 21-1 and the significance of the Cyfra 21-1 test in the diagnosis, monitoring, and treatment of lung cancer | Vinmec
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer. | Semantic Scholar
The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research
CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous squamous cell carcinoma? | SpringerLink
Table 2 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar
Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer - Yoshimura - Translational Lung Cancer Research
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - ScienceDirect
Ultrasensitive label-free detection for lung cancer CYFRA 21-1 DNA based on ring-opening polymerization - ScienceDirect
Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict objective response to chemotherapy in patients with non-small cell lung cancer
Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer - Chemical Communications (RSC Publishing)
Cancers | Free Full-Text | Current and Prospective Protein Biomarkers of Lung Cancer
New Immunosensing-Fluorescence Detection of Tumor Marker Cytokeratin-19 Fragment (CYFRA 21-1) Via Carbon Quantum Dots/Zinc Oxide Nanocomposite | Discover Nano
El CYFRA 21-1 en pacientes con sospecha de cáncer: evaluación de un punto de corte óptimo para evaluar la eficacia diagnóstica y el valor pronóstico
Cancers | Free Full-Text | The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer